Moreover, findings of fixed drug eruptions, SJS/TEN, drug-induced pruritus, and Sweet syndrome/acute febrile neutrophilic dermatosis have been linked with the commencement of SGLT2 inhibitors and subsided after discontinuing them. The gene discussed is SLC5A2; the disease is Schwartz-Jampel syndrome.